πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6555127

Multi-spike release formulation for oral drug delivery

Pharmaceutical Discovery Corporation Β· Granted Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6555116

Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin

The Regents of the University of California Β· Granted Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6552058

Oxazolidinedione derivatives and their use

Takeda Chemical Industries Ltd. Β· Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6551989

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California Β· Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6552006

Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6552053

Controlling attention and memory by altering neuronal carbonic anhydrase activity

The United States of America, as represented by the Secretary, Health and Human Services Β· Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6552054

Chromone derivatives, process for the preparation of the same and uses thereof

Takeda Chemical Industries Ltd. Β· Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6551830

Rh blood group antigen compositions and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6551774

Diagnostic methods for conditions associated with elevated cellular levels of telomerase a

The Board of Regents of the University of Texas System Β· Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6551588

Tumor radiosensitization using gene therapy

The Regents of the University of California Β· Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6551559

Sol-gel coated polarization vessels

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6548081

Bioabsorbable composites of derivatized hyaluronic acid and other biodegradable, biocompat

ANIKA THERAPEUTICS, INC. Β· Granted Tue Apr 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6548068

Enhanced immune response to an antigen by a composition of a recombinant virus expressing

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6545149

Synthesis and crystallization of piperazine ring-containing compounds

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6545142

Single domain ligands, receptors comprising said ligands, methods for their production, an

Medical Research Council of the United Kingdom Β· Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6545009

Retinoid-related receptor function regulating agent

Takeda Chemical Industries Ltd. Β· Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6544999

Polymorphs of N-methyl-N-(3-{3-[2- thienylcarbonyl]-pyrazol-[1,5-&agr;]- pyrimidin-9-yl}ph

Neurocrine Biosciences, Inc. Β· Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6544549

Multilamellar coalescence vesicles (MLCV) containing biologically active compounds

Biomira USA Inc. Β· Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6544750

Peptide analogs as selective inhibitors of thrombin activation of protease activated recep

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6541001

Vaccine composition and method of using the same

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Apr 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6541469

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Apr 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6541230

Detoxification with sponges or foams containing plurality of enzymes and encapsulated indi

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6541199

Identification of a new ehrlichia species from a patient suffering from ehrlichiosis

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6541195

Correction of genetic defects using chemical chaperones

The Regents of the University of California Β· Granted Tue Apr 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired